PraXsyn Announces That Its Subsidiary Mesa Pharmacy is Now Licensed in Illinois and Wisconsin

PALO ALTO, Calif., May 14, 2014 -- PraXsyn Corporation (OTCQB:PAWS), is pleased to announce that its pharmacy license applications, in the great State of Illinois and America's Dairyland, Wisconsin, were just approved.

"We are extremely excited to add these 2 great states to our list of states where we can dispense or ship medications. Together, these states have the potential of rivaling California as an extremely lucrative market for PraXsyn's pain management creams," said Dan Wiesel, CEO of PraXsyn. "PraXsyn's strategy is to provide an alternative to oral pain medications throughout the United States, and Illinois is just the first step in our expansion."

PraXsyn Sales Approximately $11M for April; Up From $8.8M in March

PALO ALTO, Calif., May 5, 2014 -- PraXsyn Corporation (OTCQB:PAWS) announces that after reporting March sales of $8.8M, April sales have increased to approximately $11M. "We are excited about the growth in sales, and we are looking forward to continued growth," said Dan Wiesel CEO of PraXsyn. Additionally, PraXsyn has asked DBB McKennon to become the company's new auditor. With the business in rapid growth, we felt that a local auditor would be more efficient working with the PraXsyn management team.

The PAWS Pet Company’s (PraXsyn) 10K was filed this afternoon.

PALO ALTO, CA, April 23, 2014 -- The PAWS Pet Company, Inc. (OTCQB: PAWS), announces that its 10K filing was submitted to the SEC this afternoon. “We would like to thank our auditors and our financial team that worked around the clock to get it done,” said Dan Wiesel, CEO of The PAWS Pet Company. “With the 10K complete, we are looking forward to filing the 10Q which will incorporate the results of our new merger partner Mesa Pharmacy”.
 

March Sales at Wholly-Owned Subsidiary Mesa Pharmacy exceed $8.8M.

John Garbino and Ed Kurtz Join Board of Directors
Name change imminent.
 
PALO ALTO, CA, April 9, 2014 -- The PAWS Pet Company, Inc. (OTCQB: PAWS), announced it completed the merger of Pharmacy Development Corp. (PDC), the parent company of MESA Pharmacy, Inc. (“Mesa”) into PDC, Inc. (PDCINC), PAWS wholly-owned subsidiary on March 31, 2014.
 

Pages